1-(3-Chloro-5-trifluoromethyl-pyridin-2-ylmethyl)-piperazine, 95.0%, 1g

(R)-METHYL 2-AMINO-2-(2-CHLOROPHENYL)ACETATE HYDROCHLORIDE, 95%, 5g

Omipalisib, 99.93%, 10mg

Bromoetano, min 99,5%, para síntesis, 2,5 L, envase de vidrio

{5-FLUORO-1-[TRIS(PROPAN-2-YL)SILYL]-1H-INDOL-4-YLBORONIC ACID, 95.0%, 100mg

4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-benzamide, 95.0%, 1g

2-(2-chloroethyl)-2-azabicyclo[2.2.1]heptane hydrochloride, 95.0%, 250mg

Boc-L-Serine-beta-Lactone, 96.0%, 1g

1-(1-pyrrolidinyl)cyclopentanecarboxylic acid hydrochloride, 95.0%, 5g

Ethyl 4-hydrazinyl-3-nitrobenzoate, 98%, 250mg

4-(3-fluorobenzoyl)-8-methyl-1-oxa-4-azaspiro[4.5]decane-3-carboxylic acid, 95.0%, 2g

Potassium bromate, = 99.8% (Titration: anhydrous basis), 100g

1,3,5-Triphenyl-1,5-pentanedione, 100mg